News and Comments

Biogen: A Fruitful Collaboration in Gene Therapy. A Small Gene Therapy Firm That You Should Know

  Tuesday, May 17, 2016

COLLABORATIONS  More...

Biogen Idec Pays Elan $3.25 billion For Tysabri. Do We Leave, Or Stay?

  Wednesday, February 06, 2013

 More...

Elan's Choices

  Saturday, April 16, 2011

Biogen Idec (BIIB) announced positive results of a process aimed at Identifying high-risk patients for a life-threatening side effect of prolonged use of the multiple sclerosis drug Tysabri. This test is a necessity because it detects an antibody that points to the presence of the Polyomavirus JC (JC virus), which causes the life-threatening progressive multifocal leukoencephalopathy (PML). This side effect in one per thousand patients has deprived Elan from billions of dollars in expected sales of Tysabri.  More...


Recent Postings


Archive


Tags

BIOMARIN (BMRN) Abbott Laboratories (ABT) ADVENTRIX (ANX) ABBVIE (ABBV) Revlimid (lenolidamide) Theravance Bio Pharma (TBPH) Ziofpharm (ZIOP) Onyx (ONXX) MODERNA Valeant Pharmaceuticals International (VRX) Alder Biopharmaceuticals (ALDR) Array Pharmaceuticals (ARRY) ARCA (ABIO) Bristol-Myers Squibb (BMY) GUARDIAN HEALTH Theravance (THRX) ARGOS (ARGS) Gilead (GILD) Exelixis (EXEL) Biocryst (BCRX) Illumina (ILMN) Rapamune Velcade (bortezomib) Intercept (ICPT) Anacor (ANAC) PTC Therapeutics (PTCT) NOVOCURE (NVCR) ImmunoGen (IMGN) Ionis (IONS) SYNTA (SNTA) Sanofi (SNY) Vertex (VRTX) Agenus (AGEN OSI (OSIP) Telaprevir Amgen (AMGN) Roche (RHHBY) Cytokinetics (CYTK) Endometrial Cancer Spike Therapeutics (ONCE) KERYX (KERX) JUNO (JUNO) RenenxBio (RGNX) Galena (GALE) Dendreon (DNDN) IDERA (IDRA) REGULUS (RGLS) Regeneron (REGN) HALOZYME (HALO) Roche (ROCHE) Alnylam (ALNY) Sangamo (SGMO) Dynavax (DVAX) Trastuzumab-DM1 Biogen Idec (BIIB) Zerenex Intrexon (XON) Vitae Pharmaceuticals (VTAE) Human Genome Sciences (HGSI) Pluristem (PSTI) Anadys (ANDS) galapagos (GLPG) Prosensa (RNA) Human Longevity (HLI) Sarepta (SRPT) Prolor Biotech (PBTH) CompuGen (CGEN) Editas (EDIT) NEKTAR (NKTR)) Mirati Therapeutics (MRTX) Ariad (ARIA) SUNESIS PHARMACEUTICALS (SNSS) AGOS (ARGS) Sanofi (SNA) AstraZeneca (AZN) Xoma (XOMA) SERES THERAPEUTICS (MCRB) GlaxoSmithKline (GSK) Elan (ELN) Seattle Genetics (SGEN) Intermune (ITMN) Aimmune Therapeutics (AIMT) Genentech Agenus (AGEN) Sequenom (SQNM) Auspex (ASPX) Ridaforolimus AERIE PHARMACEUTICALS Tysabri Micromet (MITI) Jazz Pharmaceuticals (JAZZ) INNOVIVA (INVA) Merck (MRK) TOKAI (TKAOI) Multiple Myeloma NANTKWEST (NK) ZALTRAP™ VANDA (VNDA) ISIS (ISIS) Sanofi-Aventis (SAN) Inovio (INO) Idenix (IDIX) Incyte (INCY) KITE (KITE) C4 Therapeutics Global Cell Therapeutics (GBT) Benlysta (belimumab) Herceptin ACADIA (ACAD)